1. Home
  2. EXPO vs IRON Comparison

EXPO vs IRON Comparison

Compare EXPO & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Exponent Inc.

EXPO

Exponent Inc.

HOLD

Current Price

$56.69

Market Cap

2.8B

ML Signal

HOLD

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$68.64

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXPO
IRON
Founded
1967
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.6B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
EXPO
IRON
Price
$56.69
$68.64
Analyst Decision
Buy
Strong Buy
Analyst Count
3
11
Target Price
$88.00
$103.18
AVG Volume (30 Days)
546.6K
439.6K
Earning Date
04-30-2026
05-07-2026
Dividend Yield
1.87%
N/A
EPS Growth
N/A
N/A
EPS
0.59
N/A
Revenue
$582,014,000.00
N/A
Revenue This Year
$12.75
N/A
Revenue Next Year
$8.50
$283.52
P/E Ratio
$93.85
N/A
Revenue Growth
4.21
N/A
52 Week Low
$51.91
$40.00
52 Week High
$81.95
$99.50

Technical Indicators

Market Signals
Indicator
EXPO
IRON
Relative Strength Index (RSI) 40.20 50.91
Support Level $51.91 $64.39
Resistance Level $73.75 $71.85
Average True Range (ATR) 1.90 3.10
MACD 0.11 -0.19
Stochastic Oscillator 34.33 48.13

Price Performance

Historical Comparison
EXPO
IRON

About EXPO Exponent Inc.

Exponent Inc is a science and engineering consulting firm that provides solutions to complex problems. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which account for the majority of revenue, provide servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Share on Social Networks: